BSX Financial Facts
Income (loss) before income taxes: 257MSelling, general and administrative expenses: 772M
See Full Income Statement
See Full Balance Sheet
Boston Scientific (BSX) Earnings
|
Expand Research on BSX
| Next EPS Date | 7/23/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +5.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -1.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/29/26  |
Q126 | N/A | $0.79 | N/A | N/A | $5.18B | = | N/A | N/A | ||
| 2/4/26 | Q425 | $0.80 | $0.78 | +$0.02 | $5.29B | $5.28B | = |  | | Details | |
| 10/22/25 | Q325 | $0.75 | $0.71 | +$0.04 | $5.07B | $4.97B | = | | | Details | |
| 7/23/25 | Q225 | $0.75 | $0.73 | +$0.02 | $5.06B | $4.89B | = | | | Details | |
| 4/23/25 | Q125 | $0.75 | $0.67 | +$0.08 | $4.66B | $4.57B | = | | | Details | |
| 2/5/25 | Q424 | $0.70 | $0.66 | +$0.04 | $4.56B | $4.41B | = | | | Details | |
| 10/23/24 | Q324 | $0.63 | $0.59 | +$0.04 | $4.21B | $4.04B | = | | | Details | |
| 7/24/24 | Q224 | $0.62 | $0.58 | +$0.04 | $4.12B | $4.02B | = | | | Details |
